During the past decade the accomplishments of our research effort have established the liver as a novel and important model in which to characterize the autocrine and paracrine mediator response of platelet- activating factor. Our experiments have provided insights into the nature and regulatory characteristics of the PAF receptor and have provided at least a glimpse of the importance of PAF as a mediator of hepatic responses to systemic and localized hepatic pathophysiology. PAF is synthesized in Acting through specific receptors and well defined signal transduction mechanisms, activation of glycogenolysis and glucose output. Temporally later in a trauma-response view, represents a key factor in regulating the entry of inflammatory cells from the circulation into the compromised liver. In the next grant period we will pursue four major experimental issues designed to characterize: 1) the regulation of two key of PAF receptor mRNA synthesis, and 4) the role of PAF as an inflammatory mediator in three relevant models of hepatic injury, e.g., ischemia/reperfusion, bile duct ligation-induced jaundice and sepsis/endotoxemia. In each of these hepatic injury models we have measured an increase in the hepatic PAF content and we need to understand the consequences of this finding which impinge upon the hemodynamic and metabolic functions of the liver. Our efforts will be aided greatly by several novel reagents developed during the past grant period, the most important of which are specific anti-PAF receptor antibodies to be employed in studies of the regulatory mechanisms of the proposed study will be the solubilization, stabilization and purification of the acety1CoA::lysoPAF acetyltransferase which most probably is the key regulatory step in PAF synthesis in macrophage-type cells. Successful outcomes from our proposed experiments will make a significant contribution to our knowledge-based concerning the inter- and intracellular signaling mechanisms operative in the mammalian liver as its responds to pathophysiological episodes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
2R01DK033538-11
Application #
2139096
Study Section
Physiological Chemistry Study Section (PC)
Project Start
1984-04-01
Project End
1998-03-31
Budget Start
1994-04-01
Budget End
1995-03-31
Support Year
11
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Texas Health Science Center San Antonio
Department
Biochemistry
Type
Schools of Medicine
DUNS #
800772162
City
San Antonio
State
TX
Country
United States
Zip Code
78229
Gandhi, C R; Harvey, S A; Cevallos, M et al. (2001) A23187 causes release of inositol phosphates from cultured rat Kupffer cells. Eur J Pharmacol 415:13-8
Howard, K M; Olson, M S (2000) The expression and localization of plasma platelet-activating factor acetylhydrolase in endotoxemic rats. J Biol Chem 275:19891-6
Svetlov, S I; Sturm, E; Olson, M S et al. (1999) Hepatic regulation of platelet-activating factor acetylhydrolase and lecithin:cholesterol acyltransferase biliary and plasma output in rats exposed to bacterial lipopolysaccharide. Hepatology 30:128-36
Mustafa, S B; Olson, M S (1999) Effects of calcium channel antagonists on LPS-induced hepatic iNOS expression. Am J Physiol 277:G351-60
Mustafa, S B; Flickinger, B D; Olson, M S (1999) Suppression of lipopolysaccharide-induced nitric oxide synthase expression by platelet-activating factor receptor antagonists in the rat liver and cultured rat Kupffer cells. Hepatology 30:1206-14
Svetlov, S I; Howard, K M; Debuysere, M S et al. (1998) Secretory PAF-acetylhydrolase of the rat hepatobiliary system: characterization and partial purification. Am J Physiol 274:G891-900
Mustafa, S B; Olson, M S (1998) Expression of nitric-oxide synthase in rat Kupffer cells is regulated by cAMP. J Biol Chem 273:5073-80
Svetlov, S I; Liu, H; Chao, W et al. (1997) Regulation of platelet-activating factor (PAF) biosynthesis via coenzyme A-independent transacylase in the macrophage cell line IC-21 stimulated with lipopolysaccharide. Biochim Biophys Acta 1346:120-30
Howard, K M; Miller, J E; Miwa, M et al. (1997) Cell-specific regulation of expression of plasma-type platelet-activating factor acetylhydrolase in the liver. J Biol Chem 272:27543-8
Siafaka-Kapadai, A; Hanahan, D J; Javors, M A (1997) Oleic acid-induced Ca2+ mobilization in human platelets: is oleic acid an intracellular messenger? J Lipid Mediat Cell Signal 15:215-32

Showing the most recent 10 out of 33 publications